Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRIM21-mediated degradation of HILPDA overcomes anti-PD-1 immunotherapy resistance in breast cancer by limiting PD-L1 palmitoylation. | Oncogene | 2026 | 41876831 | PubTator, text mining | PubMed |
| KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival. | Sci Adv | 2026 | 41849608 | PubTator, text mining | PubMed |
| Heterogeneity and Regulatory Mechanisms of ALK-Mutant and Wild-Type Epithelial Cells in Non-Small-Cell Lung Cancer: Single-Cell Transcriptomics and Chromatin Accessibility. | Pharmacology | 2026 | 41818350 | PubTator, text mining | PubMed |
| Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy. | Clin Transl Med | 2026 | 41804750 | PubTator, text mining | PubMed |
| USP20, a Super-enhancer Regulated Gene, Promotes Acute Myeloid Leukemia Progression through CTNNB1 Deubiquitination. | Int J Biol Sci | 2026 | 41800264 | PubTator, text mining | PubMed |
| Integrative epigenetic and transcriptomic profiling of whole blood and fibroblasts in Hao-Fountain syndrome. | Front Cell Dev Biol | 2026 | 41799441 | PubTator, text mining | PubMed |
| RNA N4-acetylcytidine modification in human cancers: from molecular function to oncogenic mechanisms. | iScience | 2026 | 41797923 | PubTator, text mining | PubMed |
| Krüppel-like factor 10 promotes the progression of breast cancer by activating canonical NF-κB signaling. | iScience | 2026 | 41797918 | PubTator, text mining | PubMed |
| Mechanistic insights into inflammatory cytokines in adenomyosis‑induced infertility (Review). | Int J Mol Med | 2026 | 41789648 | PubTator, text mining | PubMed |
| Lactylation: a metabolic-epigenetic bridge in diabetic kidney disease and a therapeutic target for TCM. | Chin Med | 2026 | 41787542 | PubTator, text mining | PubMed |
| Decoding the Anti-Tumour Mechanism of ɑ-Solanine: SRC Inhibition and Ferroptosis Induction in Colon Cancer. | IET Syst Biol | 2026 | 41787063 | PubTator, text mining | PubMed |
| Zinc finger proteins (ZFPs) in health and disease. | Mol Biomed | 2026 | 41772312 | PubTator, text mining | PubMed |
| Ferroptosis and cuproptosis in head and neck squamous cell carcinoma: interconnected mechanisms and therapeutic implications. | Front Pharmacol | 2026 | 41769686 | PubTator, text mining | PubMed |
| Proteasomal control of transcription factors: mechanisms, regulation and dysregulation. | Cell Mol Life Sci | 2026 | 41764121 | PubTator, text mining | PubMed |
| Pulp-Dentin Regeneration via Cell Homing: Current Evidence and Perspectives on Cell-Free Regenerative Endodontic Therapy. | Medicina (Kaunas) | 2026 | 41752774 | PubTator, text mining | PubMed |
| Selenium-Thioredoxin Axis Contributes to Ferroptosis Resistance in Pancreatic Cancer Cells. | Int J Mol Sci | 2026 | 41752199 | PubTator, text mining | PubMed |
| SMURF1 Downregulation Highlights Its Potential Role in Breast Cancer. | Int J Mol Sci | 2026 | 41752056 | PubTator, text mining | PubMed |
| Genetically Shared Signatures Between COVID-19 and Cancer Identified Through In Silico Case-Control Analysis. | Genes (Basel) | 2026 | 41751534 | PubTator, text mining | PubMed |
| SDC4 is a novel target of the KLF5 transcription factor. | Biochem Biophys Res Commun | 2026 | 41747442 | PubTator, text mining | PubMed |
| Single-Cell Multi-Omics Profiling of Human Septal Myectomy Tissue: Toward Precision Medicine in Obstructive Hypertrophic Cardiomyopathy. | J Pers Med | 2026 | 41745380 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=3